BC Week In Review | Nov 23, 2015
Clinical News

DS003: Phase I started

IPM began the double-blind, placebo-controlled, Belgian Phase I IPM 042 trial to evaluate single 1, 3 and 10 mg DS003 vaginal tablets in about 36 healthy female volunteers. The non-profit IPM has a royalty-free license...
Items per page:
1 - 1 of 1